The U.S. market is projected to reach USD 0.08 Billion and Europe USD 0.07 Billion by 2035, driven by non-invasive pain management and rehabilitation demand.
The U.S. market is projected to reach USD 0.08 Billion and Europe USD 0.07 Billion by 2035, driven by non-invasive pain management and rehabilitation demand.